Literature DB >> 26791737

Cinnamaldehyde Analogues as Potential Therapeutic Agents.

Bang-Jiao Chen, Chun-Sheng Fu, Guo-Hui Li, Xiao-Ning Wang, Hong-Xiang Lou, Dong-Mei Ren1, Tao Shen.   

Abstract

Cinnamaldehyde analogues are a class of chemical substances originated from derivatization of cinnamaldehyde, and are structurally characterized by the presence of cinnamoyl moiety. Due to the presence of highly reactive α,α-unsaturated carbonyl pharmacophore (Michael acceptor) in their structures, these molecules are apt to react with some enzymes and/or receptors as electrophiles, and consequently produce diverse therapeutically relevant pharmacological functions. Naturally occurring molecules, trans-cinnamaldehyde (CA), 2-benzoyloxycinnam-aldehyde (2-BCA), and 2- hydroxycinnamaldehyde (2-HCA) are representatives of this group, and have attracted lots of interest for their bioactivities, especially the anti-cancer and anti-inflammatory properties. Owing to the potential of CA, 2-BCA, and 2-HCA as therapeutic agents, researches on chemical syntheses and modifications have been carried out to gain chemical entities with potent bioactivity and favorable druggability. This review summarizes the progress on phytochemical and pharmacological aspects of natural cinnamaldehyde analogues, illustrate the representative of synthetic molecules with potent bioactivity, and discuss their potential as therapeutic agents.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 26791737     DOI: 10.2174/1389557516666160121120744

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  8 in total

1.  Cinnamaldehyde prevents intergenerational effect of paternal depression in mice via regulating GR/miR-190b/BDNF pathway.

Authors:  Zhi-Ying Gao; Tian-Yu Chen; Ting-Ting Yu; Li-Ping Zhang; Si-Jie Zhao; Xiao-Yang Gu; Ying Pan; Ling-Dong Kong
Journal:  Acta Pharmacol Sin       Date:  2022-01-04       Impact factor: 7.169

2.  Therapeutic Potential and Safety of the Cinnamomum zeylanicum Methanolic Extract Against Chronic Toxoplasma gondii Infection in Mice.

Authors:  Abdullah D Alanazi; Hamdan I Almohammed
Journal:  Front Cell Infect Microbiol       Date:  2022-06-09       Impact factor: 6.073

3.  Identification of novel Nrf2 activators from Cinnamomum chartophyllum H.W. Li and their potential application of preventing oxidative insults in human lung epithelial cells.

Authors:  Ming-Xing Zhou; Guo-Hui Li; Bin Sun; You-Wei Xu; Ai-Ling Li; Yan-Ru Li; Dong-Mei Ren; Xiao-Ning Wang; Xue-Sen Wen; Hong-Xiang Lou; Tao Shen
Journal:  Redox Biol       Date:  2017-09-14       Impact factor: 11.799

4.  Anti-borreliae efficacy of selected organic oils and fatty acids.

Authors:  Anna Goc; Aleksandra Niedzwiecki; Matthias Rath
Journal:  BMC Complement Altern Med       Date:  2019-02-04       Impact factor: 3.659

5.  Cinnamaldehyde Enhances Antimelanoma Activity through Covalently Binding ENO1 and Exhibits a Promoting Effect with Dacarbazine.

Authors:  Weiyi Zhang; Jie Gao; Chuanjing Cheng; Man Zhang; Wenjuan Liu; Xiaoyao Ma; Wei Lei; Erwei Hao; Xiaotao Hou; Yuanyuan Hou; Gang Bai
Journal:  Cancers (Basel)       Date:  2020-01-29       Impact factor: 6.639

Review 6.  Natural Cinnamaldehyde and Its Derivatives Ameliorate Neuroinflammatory Pathways in Neurodegenerative Diseases.

Authors:  Mehrdad Hajinejad; Maryam Ghaddaripouri; Maryam Dabzadeh; Fatemeh Forouzanfar; Sajad Sahab-Negah
Journal:  Biomed Res Int       Date:  2020-11-14       Impact factor: 3.411

7.  Appraisal of Cinnamaldehyde Analogs as Dual-Acting Antibiofilm and Anthelmintic Agents.

Authors:  Sagar Kiran Khadke; Jin-Hyung Lee; Yong-Guy Kim; Vinit Raj; Jintae Lee
Journal:  Front Microbiol       Date:  2022-03-16       Impact factor: 5.640

8.  Bis-pharmacophore of cinnamaldehyde-clubbed thiosemicarbazones as potent carbonic anhydrase-II inhibitors.

Authors:  Asif Rasool; Zahra Batool; Majid Khan; Sobia Ahsan Halim; Zahid Shafiq; Ahmed Temirak; Mohamed A Salem; Tarik E Ali; Ajmal Khan; Ahmed Al-Harrasi
Journal:  Sci Rep       Date:  2022-09-27       Impact factor: 4.996

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.